Browse > Article
http://dx.doi.org/10.1016/j.jgr.2020.08.001

Prebiotics enhance the biotransformation and bioavailability of ginsenosides in rats by modulating gut microbiota  

Zhang, Xiaoyan (Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences)
Chen, Sha (Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences)
Duan, Feipeng (Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences)
Liu, An (Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences)
Li, Shaojing (Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences)
Zhong, Wen (Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences)
Sheng, Wei (College of Life Science, Huaibei Normal University)
Chen, Jun (Big Data and Engineering Research Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health)
Xu, Jiang (Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences)
Xiao, Shuiming (Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences)
Publication Information
Journal of Ginseng Research / v.45, no.2, 2021 , pp. 334-343 More about this Journal
Abstract
Background: Gut microbiota mainly function in the biotransformation of primary ginsenosides into bioactive metabolites. Herein, we investigated the effects of three prebiotic fibers by targeting gut microbiota on the metabolism of ginsenoside Rb1 in vivo. Methods: Sprague Dawley rats were administered with ginsenoside Rb1 after a two-week prebiotic intervention of fructooligosaccharide, galactooligosaccharide, and fibersol-2, respectively. Pharmacokinetic analysis of ginsenoside Rb1 and its metabolites was performed, whilst the microbial composition and metabolic function of gut microbiota were examined by 16S rRNA gene amplicon and metagenomic shotgun sequencing. Results: The results showed that peak plasma concentration and area under concentration time curve of ginsenoside Rb1 and its intermediate metabolites, ginsenoside Rd, F2, and compound K (CK), in the prebiotic intervention groups were increased at various degrees compared with those in the control group. Gut microbiota dramatically responded to the prebiotic treatment at both taxonomical and functional levels. The abundance of Prevotella, which possesses potential function to hydrolyze ginsenoside Rb1 into CK, was significantly elevated in the three prebiotic groups (P < 0.05). The gut metagenomic analysis also revealed the functional gene enrichment for terpenoid/polyketide metabolism, glycolysis, gluconeogenesis, propanoate metabolism, etc. Conclusion: These findings imply that prebiotics may selectively promote the proliferation of certain bacterial stains with glycoside hydrolysis capacity, thereby, subsequently improving the biotransformation and bioavailability of primary ginsenosides in vivo.
Keywords
Ginsenoside; Prebiotic; Gut microbiota; Biotransformation; Bioavailability;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Niu T, Smith DL, Yang Z, Gao S, Yin T, Jiang ZH, You M, Gibbs RA, Petrosino JF, Hu M. Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencing. Pharm Res 2013;30:836-46.   DOI
2 Kekkonen RA, Holma R, Hatakka K, Suomalainen T, Poussa T, Adlercreutz H, Korpela R. A probiotic mixture including galactooligosaccharides decreases fecal β-glucosidase activity but does not affect serum enterolactone concentration in men during a two-week intervention. J Nutr 2011;141:870-6.   DOI
3 Larkin TA, Price WE, Astheimer LB. Increased probiotic yogurt or resistant starch intake does not affect isoflavone bioavailability in subjects consuming a high soy diet. Nutrition 2007;23:709-18.   DOI
4 Hemmerly TE. A ginseng farm in Lawrence County, Tennessee. Econ Bot 1977;31:160-2.   DOI
5 Leung KW, Wong ST. Pharmacology of ginsenosides: a literature review. Chin Med 2010;5:20.   DOI
6 Akao T, Kanaoka M, Kobashi K. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration-measurement of compound K by enzyme immunoassay. Biol Pharm Bull 1998;21:245-9.   DOI
7 Yan X, Fan Y, Wei W, Wang P, Liu Q, Wei Y, Zhang L, Zhao G, Yue J, Zhou Z. Production of bioactive ginsenoside compound K in metabolically engineered yeast. Cell Res 2014;24:770-3.   DOI
8 Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol 1998;50:1155-60.   DOI
9 Wang CZ, Du GJ, Zhang Z, Wen XD, Calway T, Zhen Z, Musch MW, Bissonnette M, Chang EB, Yuan CS. Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer. Int J Oncol 2012;40:1970-6.   DOI
10 Kim DH. Chemical diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng. J Gins Res 2012;36:1-15.   DOI
11 Lee J, Lee E, Kim D, Lee J, Yoo J, Koh B. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J Ethnopharmacol 2009;122:143-8.   DOI
12 Hasegawa H, Sung JH, Benno Y. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med 1997;63:436-40.   DOI
13 Kim KA, Yoo HH, Gu W, Yu DH, Jin MJ, Choi HL, Yuan K, Guerin-Deremaux L, Kim DH. Effect of a soluble prebiotic fiber, NUTRIOSE, on the absorption of ginsenoside Rd in rats orally administered ginseng. J Gins Res 2014;38:203-7.   DOI
14 Marteau P, Pochart P, Flourie B, Pellier P, Santos L, Desjeux JF, Rambaud JC. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am J Clin Nutr 1990;52:685-8.   DOI
15 Yang L, Akao T, Kobashi K. Purification and characterization of a geniposide-hydrolyzing β-glucosidase from Euhacterium sp. A-44, a strict anaerobe from human feces. Biol Pharm Bull 1995;18:1175-8.   DOI
16 Kim KA, Yoo HH, Gu W, Yu DH, Jin MJ, Choi HL, Kim DH, Yuan K, Guerin-Deremaux L. A prebiotic fiber increases the formation and subsequent absorption of compound K following oral administration of ginseng in rats. J Gins Res 2015;39:183-7.   DOI
17 Roberfroid MB, Loo JA, Van, Gibson GR. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 1998;128:11-9.   DOI
18 Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 2004;95:153-7.   DOI
19 Goossens D, Jonkers D, Russel M, Stobberingh E, Bogaard AVD, Stockbrugger R. The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects. Aliment Pharmacol Ther 2003;18:495-505.   DOI
20 Kim KA, Jung IH, Park SH, Ahn YT, Huh CS, Kim DH. Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K. PLoS One 2013;8:e62409.   DOI
21 Avgustin G, Ramsak A, Peterka M. Systematics and evolution of ruminal species of the genus Prevotella. Folia Microbiol 2001;46:40-4.   DOI
22 Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, Owens SM, Betley J, Fraser L, Bauer M. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 2012;6:1621-4.   DOI
23 Nettleton JA, Greany KA, Thomas W, Wangen KE, Adlercreutz H, Kurzer MS. The effect of soy consumption on the urinary 2:16-hydroxyestrone ratio in postmenopausal women depends on equol production status but is not influenced by probiotic consumption. J Nutr 2005;135:603-8.   DOI
24 Cohen LA, Crespin JS, Wolper C, Zang EA, Pittman B, Zhao Z, Holt PR. Soy isoflavone intake and estrogen excretion patterns in young women: effect of probiotic administration. In Vivo 2007;21:507-12.
25 Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004;17:259-75.   DOI
26 Xu J, Chen HB, Li SL. Understanding the molecular mechanisms of the interplay between herbal medicines and gut microbiota. Med Res Rev 2017;37: 1140-85.   DOI
27 Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 2005;3:431-8.   DOI
28 Liu Z, Sun Y, Zhang Y, Feng W, Lai Z, Fa K, Qin S. Metagenomic and 13C tracing evidence for autotrophic atmospheric carbon absorption in a semiarid desert. Soil Biol Biochem 2018;125:156-66.   DOI
29 Lefranc-Millot C, Guerin-Deremaux L, Wils D, Neut C, Miller L, Saniez-Degrave M. Impact of a resistant dextrin on intestinal ecology: how altering the digestive ecosystem with NUTRIOSE®, a soluble fibre with prebiotic properties, may be beneficial for health. J Int Med Res 2012;40:211-24.   DOI
30 Chen Y, Xiao S, Gong Z, Zhu X, Yang Q, Li Y, Gao S, Dong Y, Shi Z, Wang Y, et al. Wuji Wan formula ameliorates diarrhea and disordered colonic motility in post-inflammation irritable bowel syndrome rats by modulating the gut microbiota. Front Microbiol 2017;8:2307.   DOI
31 Luo R, Liu B, Xie Y, Li Z, Huang W, Yuan J, He G, Chen Y, Pan Q, Liu Y, et al. SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. GigaScience 2012;1:18.   DOI
32 Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, Arumugam M, Kultima JR, Prifti E, Nielsen T, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014;32:834-41.   DOI
33 Fu L, Niu B, Zhu Z, Wu S, Li W. Cd-Hit: Accelerated for clustering the next-generation sequencing data. Bioinformatics 2012;28:3150-2.   DOI
34 Li R, Yu C, Li Y, Lam TW, Yiu SM, Kristiansen K, Wang J. SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 2009;25:1966-7.   DOI
35 Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004;32:D277.   DOI
36 Huson DH, Mitra S, Ruscheweyh HJ, Weber N, Schuster SC. Integrative analysis of environmental sequences using MEGAN4. Genome Res 2011;21:1552-60.   DOI
37 Park BH, Karpinets TV, Syed MH, Leuze MR, Uberbacher EC. CAZymes Analysis Toolkit (CAT): web service for searching and analyzing carbohydrate-active enzymes in a newly sequenced organism using CAZy database. Glycobiology 2010;20:1574.   DOI
38 Wilson ID, Nicholson JK. The role of gut microbiota in drug response. Curr Pharm Des 2009;15:1519-23.   DOI
39 Doestzada M, Vila AV, Zhernakova A, Koonen DPY, Weersma RK, Touw DJ, Kuipers F, Wijmenga C, Fu J. Pharmacomicrobiomics: a novel route towards personalized medicine? Protein Cell 2018;9:432-45.   DOI
40 Zhou SS, Xu J, Zhu H, Wu J, Xu JD, Yan R, Li XY, Liu HH, Duan SM, Wang Z. Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction. Sci Rep 2016;6:22474.   DOI
41 Saad R, Rizkallah MR, Aziz RK. Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes. Gut Pathog 2012;4:16.   DOI
42 Rossi M, Amaretti A, Leonardi A, Raimondi S, Simone M, Quartieri A. Potential impact of probiotic consumption on the bioactivity of dietary phytochemicals. J Agric Food Chem 2013;61:9551-8.   DOI
43 Lhoste EF, Ouriet V, Bruel S, Flinois JP, Brezillon C, Magdalou J, Caroline C, Lionelle NB. The human colonic microflora influences the alterations of xenobiotic-metabolizing enzymes by catechins in male F344 rats. Food Chem Toxicol 2003;41:695-702.   DOI
44 Hasebe T, Ueno N, Musch MW, Nadimpalli A, Kaneko A, Kaifuchi N, Watanabe J, Yamamoto M, Kono T, Inaba Y. Daikenchuto (TU-100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K. Pharma Res Per 2016;4:e00215.   DOI
45 Henrissat B, Bairoch A. New families in the classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem J 1993;293:781-8.   DOI
46 Park CS, Yoo MH, Noh KH, Oh DK. Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases. Appl Microbiol Biotechnol 2010;87:9-19.   DOI
47 Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. J Am Med Assoc 1997;277:301-6.   DOI
48 Haiser HJ, Turnbaugh PJ. Is it time for a metagenomic basis of therapeutics? Science 2012;336:1253-5.   DOI